← All indications
Mitochondrial Encephalomyopathies
A heterogenous group of disorders characterized by alterations of mitochondrial metabolism that result in muscle and nervous system dysfunction. These are often multisystemic and vary considerably in age at onset (usually in the first or second decade of life), distribution of affected muscles, severity, and course. (From Adams et al., Principles of Neurology, 6th ed, pp984-5)
Subtype terms (2)
More specific conditions that are subtypes of Mitochondrial Encephalomyopathies in the MeSH hierarchy.
- MELAS Syndrome
13 drugs (5 approved, 8 experimental)
- MERRF Syndrome
Drugs by status
Approved for this indication (1)
Phase 2 trials (3)
Organizations
Organization Involved with Phase 2 Indications (3)
Organization Involved with Other Experimental Indications (1)